Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis

Guo, J.-X.; Ma, H.-B.; Li, Y.-L.; Xu, J.; Yang, L.-H.; Shi, J.-B.; Li, B.; Liu, A.-X.; Li, X.-X.; Li, B.-A.; Mao, Y.-L.; Guo, J.-X; Ma, H.-B; Li, Y.-L; Xu, J; Yang, L.-H; Shi, J.-B; Li, B; Liu, A.-X; Li, X.-X; Li, B.-A; Mao, Y.-L

Home

>

Node

>

Subnode

Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis

Guo, J.-X.; Ma, H.-B.; Li, Y.-L.; Xu, J.; Yang, L.-H.; Shi, J.-B.; Li, B.; Liu, A.-X.; Li, X.-X.; Li, B.-A.; Mao, Y.-L.

Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(1): 71-73

2009

ISSN/ISBN: 1003-9279

PMID: 19799025

Document Number: 637510

To evaluate the detection method of ELISA and Enhanced Chemiluminescence Immunoassay (ECLIA) in use to determine serum hyaluronate acid (HA), laminin (LN), type IV collagen (IV-C) and type III procollagen (PC III). 253 patients with chronic hepatitis B were determined the four liver fibrosis serum markers with both the ECLIA and ELISA, and then compared with pathology results separately. Both the detection results of ELISA and ECLIA can reflect that the patient's liver fibrosis from hepatitis to liver cirrhosis aggravated gradually. Compared with ELISA, the results of ECLIA and pathology have a better correlation. The detection of four liver fibrosis serum markers by ECLIA could indicate the better the response of the state of live fibrosis.